Logo image of HCWB

HCW BIOLOGICS INC (HCWB) Stock Analyst Earnings Estimates

NASDAQ:HCWB - Nasdaq - US40423R2040 - Common Stock - Currency: USD

4.41  +0.26 (+6.27%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
HCWB revenue by date.HCWB revenue by date.
6.72M2.842M
-57.71%
2.567M
-9.68%
7.145M
178.36%

-100.00%
163.72M378.05M
130.91%
642.3M
69.90%
EBITDA
YoY % growth
HCWB ebitda by date.HCWB ebitda by date.
-14.36M
-11.93%
-24.86M
-73.12%
-27.29M
-9.77%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
HCWB ebit by date.HCWB ebit by date.
-15.08M
-12.79%
-26M
-72.41%
-28.47M
-9.50%
-28.935M
-1.63%
-37.616M
-30.00%
-47.554M
-26.42%
66.189M
239.19%
236.23M
256.90%
441.01M
86.69%
Operating Margin
HCWB operating margin by date.HCWB operating margin by date.
-224.40%-914.91%-1,109.16%-404.97%N/AN/A40.43%62.49%68.66%
EPS
YoY % growth
HCWB eps by date.HCWB eps by date.
-16.80
46.17%
-28.00
-66.67%
N/A
16.94%
-4.69
79.82%
-5.11
-8.91%
-2.77
45.71%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
1.84-2.35-2.48
22.54%
-2.65
Revenue
Q2Q % growth
7.14M
1,053.66%
N/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
3.284M
121.89%
-4.211M
-14.11%
-4.442M
-68.90%
-4.758M
-179.90%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-3.20
73.33%
3.67-6.87-187.15%
Q4 2023
Q2Q % growth
-12.00
-100.00%
-5.71-6.29-110.08%
Q3 2023
Q2Q % growth
-5.60
-27.27%
-5.30-0.30-5.58%
Q2 2023
Q2Q % growth
-4.80
-20.00%
-5.981.1819.79%
Q1 2023
Q2Q % growth
-5.60
-133.33%
-5.710.111.96%
Q4 2022
Q2Q % growth
-6.00
11.24%
-6.730.7310.87%
Q3 2022
Q2Q % growth
-4.40 -4.900.5010.13%
Q2 2022
Q2Q % growth
-4.00 -5.101.1021.57%
Q1 2022
Q2Q % growth
-2.40 -4.492.0946.52%
Q4 2021
Q2Q % growth
-6.76 -4.90-1.86-38.07%
HCWB Yearly EPS VS EstimatesHCWB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
10K
-99.11%
%
Q4 2024
Q2Q % growth
395K
-70.17%
7.14M-6.745M-94.47%
Q3 2024
Q2Q % growth
426.4K
-50.01%
%
Q2 2024
Q2Q % growth
618.9K
-0.50%
%
Q1 2024
Q2Q % growth
1.127M
2,590.31%
%
Q4 2023
Q2Q % growth
1.324M
-1.19%
918K406K44.23%
Q3 2023
Q2Q % growth
853K
-52.87%
306K547K178.76%
Q2 2023
Q2Q % growth
622K
38.22%
622K%
Q1 2023
Q2Q % growth
41.88K
-98.66%
1.173M-1.131M-96.43%
Q4 2021
Q2Q % growth

-100.00%
%
HCWB Yearly Revenue VS EstimatesHCWB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2028 2029 2030 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 79.09% 79.09%
RevenueN/A N/A N/A N/A